Bromodeoxyuridine-induced reversion of transformed characteristics in BHK21 cells: changes at the plasma membrane level.
When BHK21 cells transformed by hamster sarcoma virus are grown in the presence of 5-Bromedeoxyuridine (BUdr), several in vitro properties of the transformed cells such as morphology, adhesiveness, and alignment, revert towards a state close to that of untransformed cells. We have studied plasma membrane changes associated with this phenotypic reversion by several different biochemical methods. Reversion is accompanied by a reappearance of Fibronectin, an increase in a membrane-associated protein of M.W. 100,000 which is increased in transformed cells and a decrease in Con A-agglutinability. On the other hand, several membrane changes associated with malignant transformation namely, the increase in an integral membrane protein M.W. 177,000, the higher rate of hexose uptake, the increase in high molecular weight surface glycopeptides and, to some extent, the increase in the density of intramembranous particles, did not revert under BUdr treatment. Thus, membrane properties of transformed cells may be dissociated into two main groups by BUdr treatment. In addition, the exposure and glycosylation of a growth-regulated membrane protein M.W. 160,000 was highly sensitive to BUdr.
D000371:Agglutination; D000818:Animals; D001345:Autoradiography; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D002462:Cell Membrane / Q000378:metabolism*; D002472:Cell Transformation, Viral / Q000187:drug effects*; D002852:Chromatography, Ion Exchange; D003208:Concanavalin A / Q000494:pharmacology; D006224:Cricetinae; D003847:Deoxyglucose / Q000378:metabolism; D004591:Electrophoresis, Polyacrylamide Gel; D006020:Glycopeptides / Q000378:metabolism; D006023:Glycoproteins / Q000032:analysis; D007467:Iodoproteins / Q000378:metabolism; D008565:Membrane Proteins / Q000378:metabolism
D006020:Glycopeptides; D006023:Glycoproteins; D007467:Iodoproteins; D008565:Membrane Proteins; D003208:Concanavalin A; D003847:Deoxyglucose; D001973:Bromodeoxyuridine